Keros Therapeutics annual operating margin
2019
2021
2023
2024
2025
Keros Therapeutics Operating Margin Growth & History (KROS)
Keros Therapeutics's operating margin was 27.69% for fiscal 2025.
View full Keros Therapeutics company overviewKeros Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 27.69% | +5966.64 pp |
| 2024 | 2024-12-31 | −5,938.96% | +106604.75 pp |
| 2023 | 2023-12-31 | −112,543.71% | −112263.25 pp |
| 2021 | 2021-12-31 | −280.46% | −174.83 pp |
| 2019 | 2019-12-31 | −105.63% | — |
Keros Therapeutics quarterly operating margin
Q1.19
Q2.19
Q3.19
Q4.19
Q2.21
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −7,050.95% | −7122.93 pp |
| Q4 2025 | 2025-12-31 | −7,602.60% | −5851.97 pp |
| Q3 2025 | 2025-09-30 | −107.87% | +15009.92 pp |
| Q2 2025 | 2025-06-30 | −219.16% | +136102.46 pp |
| Q1 2025 | 2025-03-31 | 71.97% | +58485.23 pp |
| Q4 2024 | 2024-12-31 | −1,750.62% | +30735.39 pp |
| Q3 2024 | 2024-09-30 | −15,117.78% | +525882.22 pp |
| Q2 2024 | 2024-06-30 | −136,321.62% | −120780.62 pp |
| Q1 2024 | 2024-03-31 | −58,413.25% | −58304.13 pp |
| Q4 2023 | 2023-12-31 | −32,486.01% | −32392.97 pp |
| Q3 2023 | 2023-09-30 | −541,000.00% | −540893.96 pp |
| Q2 2021 | 2021-06-30 | −15,541.00% | −15426.68 pp |
| Q4 2019 | 2019-12-31 | −109.12% | — |
| Q3 2019 | 2019-09-30 | −93.04% | — |
| Q2 2019 | 2019-06-30 | −106.04% | — |
| Q1 2019 | 2019-03-31 | −114.32% | — |
Keros Therapeutics operating margin trends
Across the available reported history, Keros Therapeutics's operating margin increased from −5,938.96% to 27.69%, a change of +5966.64 percentage points. The latest reported quarter, Q1 2026, shows −7,050.95%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Keros Therapeutics filings at SEC.gov ↗